top of page
Regenerative nanomaterial enables spinal fusion with minimal growth factor
October 17, 2023
​
Scientists at Northwestern University published a new study describing a novel therapeutic for bone regeneration that induced spinal fusion with a 100-fold dose reduction in recombinant bone morphogenetic protein-2 (BMP-2) compared to current clinical products.
The study will inform development of an off-the-shelf implant for spinal fusion that induces bone growth without the harmful side effects of recombinant growth factors.
Click here to read the full study, published in the journal Biomaterials.
A spine reconstruction from microcomputed tomography imaging shows the growth of new bone (in turquoise) in a rabbit spinal fusion model.
bottom of page